(2011) used a rat Achilles tendon transection model to demonstrate that BPC-157 accelerated tendon-explant outgrowth, increased tendon fibroblast migration in a dose-dependent manner, and improved cell survival under oxidative stress conditions (5)
Think drip, not spray
Its unique peptide sequence differentiates it from other copper peptides while providing researchers with an important model for investigating copper-dependent cellular communication and peptide biology
Product Name: BPC-157 5mg Catalogue Number: BPC5-024 Molecular Formula: C62H98N16O22 Molecular Weight: 1479.6 g/mol Purity: 99% Sequence: H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH Form: Lyophilised Solid View PeptideVerify Certificate Storage and Handling: BPC-157 is supplied as a lyophilised solid to ensure maximum stability and ease of use in research environments
Choice between the four blend formats depends on how many pathways the research protocol needs in parallel
Contact your GP or prescribing clinician if you experience : Severe or worsening fatigue that significantly impairs daily activities or persists beyond several weeks of treatment Extreme weakness or inability to perform usual tasks Dizziness or fainting , particularly on standing, which may indicate dehydration or blood pressure changes Persistent nausea or vomiting preventing adequate food or fluid intake Signs of dehydration : dark urine, reduced urination, dry mouth, confusion Chest pain, palpitations, or breathlessness accompanying tiredness Mood changes , including low mood or depression, which can manifest as fatigue Right upper abdominal pain, fever or yellowing of the skin/eyes , which could indicate gallbladder problems (GLP-1 medications may increase gallstone risk) For urgent but non-emergency concerns, you can contact NHS 111 for advice